Soy phytoestrogens: Research on benefits and risks

Clinical Obstetrics and Gynecology

Volumn 44, Issue 4, 2001, Pages 843-852

  Wagner, Janice D ^a   Anthony, Mary S ^a   Cline, J Mark ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHYTOESTROGEN; SOYBEAN PROTEIN;

BREAST CANCER; CLINICAL TRIAL; DEMENTIA; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; ENDOMETRIUM CANCER; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; OSTEOPOROSIS; REVIEW; TREATMENT INDICATION;

ANIMALS; BONE DENSITY; BREAST NEOPLASMS; COGNITION; CORONARY DISEASE; ENDOMETRIAL NEOPLASMS; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; ISOFLAVONES; OSTEOPOROSIS; PATIENT COMPLIANCE; PHYTOESTROGENS; PLANT PREPARATIONS; RISK ASSESSMENT; SOYBEAN PROTEINS; TREATMENT OUTCOME;

EID: 0035202702     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200112000-00022     Document Type: Review

References (52)

1. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
2. International trends in coronary heart disease mortality, morbidity, and risk factors
3. Effects of phyto-oestrogens on tissues
4. Health potential of soy isoflavones for menopausal women
5. Meta-analysis of the effects of soy protein intake on serum lipids
6. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys
7. Inhibition of postmenopausal atherosclerosis progession: A comparison of the effects of conjugated equine estrogens and soy phytoestrogens
8. Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys
9. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins
10. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women
11. The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women
12. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women
13. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: A randomized controlled trial in humans
14. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women
15. Intact dietary soy protein, but not adding an isoflavone-rich soy extract added to casein protein improves plasma lipids in ovariectomized cynomolgus monkeys
16. Soy protein improves plasma and arterial LDL metabolism compared to casein protein with or without isoflavones
17. Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques
18. The phytoestrogens genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17β-estradiol
19. Effects of dietary phytoestrogens in postmenopausal women
20. Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women
21. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women
22. The effects of isoflavone phytoestrogens on bone; preliminary results from a large randomized controlled trial
23. The effect of soy protein on bone metabolism
24. Dietary flour supplementation decreases post-menopausal hot flushes: Effect of soy and wheat
25. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women
26. Clinical effects of a standardized soy extract in postmenopausal women: A pilot study
27. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: A multicenter, double-blind, randomized, placebo-controlled study
28. Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women
29. Dietary soy isoflavones favorably influence lipids and bone turnover in health postmenopausal women
30. Effects of soy isoflavones on blood lipids, blood pressure, and biochemical markers of bone metabolism in postmenopausal women
31. Relationship between urinary isoflavones and bone metabolism in postmenopausal Japanese women
32. Effect of soy protein on bone metabolism in postmenopausal Japanese women
33. Soy consumption and bone mineral density in older Japanese American women in King County, Washington
34. Soy intake related to menopausal sy4ptoms, serum lipids, and bone mineral density in postmenopausal Japanese women
35. Dietary soybeans intake and bone mineral density among 995 middle-aged women in Yokohama
36. Japanese intake of flavonoids and isoflavonoids from foods
37. Phyto-oestrogen excretion and rate of bone loss in postmenopausal women
38. Hormones, mood and cognitive functioning in postmenopausal women
39. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia
40. Brain aging and midlife tofu consumption
41. Tofu consumption and cognition in older Japanese American men and women
42. Effect of estradiol and soy phytoestrogens on choline acetyltransferase and nerve growth factor mRNAs in the frontal cortex and hippocampus of female rats
43. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
44. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
45. Effects of conjugated estrogens, medroxyprogesterone acetate, and tamoxifen on the mammary glands of macaques
46. Effects of mammalian and plant estrogens on mammary glands and uteri of macaques
47. Urinary phytoestrogens and postmenopausal breast cancer risk
48. Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells
49. Differential effect of genistein on transforming growth factor beta 1 expression in normal and malignant mammary epithelial cells
50. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo
51. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast
52. Association of soy and fiber consumption with the risk of endometrial cancer